Publications by authors named "Steve A Castillo"

4Publications

Long-term safety and tolerability of the lamivudine/abacavir combination as components of highly active antiretroviral therapy.

Authors:
Steve A Castillo Jaime E Hernandez Cindy H Brothers

Drug Saf 2006 ;29(9):811-26

GlaxoSmithKline, Research Triangle Park, North Carolina 27709, USA.

View Article and Find Full Text PDF
January 2007

Abacavir once or twice daily combined with once-daily lamivudine and efavirenz for the treatment of antiretroviral-naive HIV-infected adults: results of the Ziagen Once Daily in Antiretroviral Combination Study.

Authors:
Graeme J Moyle Edwin DeJesus Pedro Cahn Steve A Castillo Henry Zhao David N Gordon Charles Craig Trevor R Scott

J Acquir Immune Defic Syndr 2005 Apr;38(4):417-25

Chelsea and Westminster Hospital, HIV Clinic, London, United Kingdom.

View Article and Find Full Text PDF
April 2005

Abacavir versus zidovudine combined with lamivudine and efavirenz, for the treatment of antiretroviral-naive HIV-infected adults.

Authors:
Edwin DeJesus Gisela Herrera Eugenio Teofilo Jan Gerstoft Carlos Beltran Buendia J David Brand Cynthia H Brothers Jaime Hernandez Steve A Castillo Tab Bonny E Randall Lanier Trevor R Scott

Clin Infect Dis 2004 Oct 10;39(7):1038-46. Epub 2004 Sep 10.

IDC Research, Altamonte Springs, FL 32701, USA.

View Article and Find Full Text PDF
October 2004

Once-daily versus twice-daily lamivudine, in combination with zidovudine and efavirenz, for the treatment of antiretroviral-naive adults with HIV infection: a randomized equivalence trial.

Authors:
Edwin DeJesus Debra McCarty Charles F Farthing Denise D Shortino Beatriz Grinsztejn Deborah A Thomas Shannon R Schrader Steve A Castillo Michael G Sension Kevin Gough Sam J Madison

Clin Infect Dis 2004 Aug 15;39(3):411-8. Epub 2004 Jul 15.

IDC Research Initiative, Altamonte Springs, FL, USA.

View Article and Find Full Text PDF
August 2004